The People Who Brought You Cheaper Hepatitis C Drugs Are Going After ...
Express Scripts Holding Co. (ESRX), which this year forced price concessions from makers of $1,000-a-day hepatitis C medicines, has set its sights on $37 billion in U.S. spending on cancer medications. Its goal is to start influencing the drugs' costs ...
Bloomberg - Thu, 22 Jan 2015 12:18

Express Scripts' Miller says hepatitis C price war to save billions
Reuters - Thu, 22 Jan 2015 09:45

Gilead Sciences, Inc (GILD): More Of An HCV-Focused Company Now?
Bidness ETC - Fri, 23 Jan 2015 04:37



Senators balk at cost of hepatitis C drug, other mid-year expenses
The Medicaid program is seeking $35 million for increased prescription drug costs this fiscal year. The main cost-driver is Sovaldi, produced by California drugmaker Gilead Sciences and used to treat hepatitis C. The pills cost $87,000 for a 12-week dose.
STLtoday.com - Thu, 22 Jan 2015 15:53

Fight over supplemental budget puts focus on Medicaid funding
Columbia Daily Tribune - Sat, 24 Jan 2015 22:00



Merck Will No Longer Sell its Victrelis Hepatitis C Drug in the US
Rival hepatitis C drugs from Merck and Vertex Pharmaceuticals made a big splash when they debuted in 2011, marking an advance in treatment of the liver disease and a lucrative new market segment. But now the Class of 2011 has almost sunk to the bottom ...
Wall Street Journal (blog) - Wed, 21 Jan 2015 08:02

Another one bites the dust: Merck cans hep C fighter Victrelis as new meds ...
FiercePharma - Wed, 21 Jan 2015 09:22



State could help Fresno-area hepatitis C sufferers afford costly drugs
Painting contractor Travis Poole is back at work with his Advanced Painting business, thanks to a very expensive drug that has made him free of the hepatitis C virus, which nearly killed him. Poole says he's lucky, because the $180,000, 24-week drug ...
Fresno Bee - Tue, 20 Jan 2015 18:38



Hepatitis C: What Therapy this Week?
“We really have entered this new era of direct acting antivirals, and as of this fall, we've finally laid to rest Interferon in the grave that we've all been wanting to put it in, for more than 2 decades,” opened Jacqueline G. O'Leary, MD, MPH, AGAF ...
HCPLive - Sat, 24 Jan 2015 13:11



AbbVie's New Hepatitis C Treatment Gets Approval in EU
Drugmaker AbbVie Inc. said Monday that its new, all-pill hepatitis C combo treatment has been approved for patients in the 28 European Union member countries. The company said the European Commission granted marketing authorization for the ...
ABC News - Mon, 19 Jan 2015 11:48

AbbVie hepatitis C treatment approved in EU
Crain's Chicago Business - Tue, 20 Jan 2015 04:35

Gilead rival AbbVie's new hepatitis C treatment wins EU approval
San Jose Mercury News - Mon, 19 Jan 2015 15:25

Gilead, AbbVie rack up new payer deals, but hep C obstacles loom across the ...
FiercePharma - Tue, 20 Jan 2015 08:49

Hepatitis C drugs, Viekirax and Exviera, gets EU approval
Outbreak News Today - Tue, 20 Jan 2015 12:03

AbbVie Inc Hepatitis C Combo Therapy Wins EU Approval
Bidness ETC - Tue, 20 Jan 2015 04:50



Aetna and Gilead Reach Deal on Hepatitis C Drug
Aetna, the third-largest American health insurer, said it had negotiated a discount with Gilead Sciences for its hepatitis C treatment and would offer it as the preferred choice to its nearly 11 million commercial customers. Aetna and other insurers ...
New York Times - Fri, 16 Jan 2015 17:23

Hepatitis C drug's high cost hits California budget
Sacramento Bee - Fri, 16 Jan 2015 22:45

Aetna backs Gilead's hepatitis C treatment, gets discount
Reuters - Fri, 16 Jan 2015 11:41

Aetna Picks Gilead Sciences Hepatitis C Drugs Over AbbVie's
ABC News - Fri, 16 Jan 2015 13:56

Aetna chooses Gilead Sciences hepatitis C drugs over AbbVie's
San Jose Mercury News - Fri, 16 Jan 2015 17:12

AbbVie Strikes Hepatitis C Discount Deal With AIDS Drug Programs
Bloomberg - Fri, 16 Jan 2015 12:48

India Rejects Gilead Patent Bid for Sovaldi Hepatitis C Treatment
Wall Street Journal (blog) - Wed, 14 Jan 2015 11:26



Report calls for more testing for Hepatitis C
The new report, which gives details of a project to raise awareness and testing in Bedford, recommends that screening should be carried out on all new patients from countries with a high prevalence of Hepatitis C when they register with GP surgeries.
Bedford Today - Sun, 25 Jan 2015 01:00


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014